Episodes
Thursday Jan 23, 2020
E55: Anifrolumab for SLE (TULIP 1&2)
Thursday Jan 23, 2020
Thursday Jan 23, 2020
This week I talk about the recently published TULIP 1 and TULIP 2 trials that assessed anifrolumab for active SLE. Great to see a new drug in this disease state; interesting to think through how these trials played out. Get the papers and the pod at ebrheum.com and follow me @ebrheum if you'd like to share feedback!
Thursday Jan 16, 2020
E54: Rheum4Debate - Triple Tx is 1st Line in RA w/No Response to MTX
Thursday Jan 16, 2020
Thursday Jan 16, 2020
Happy New Year! This week Dr. Anisha Dua (@anisha_dua) and Dr. Sarah Fantus (@sarahfantus) debate this motion: "In MTX non-responders with RA, triple therapy (adding HCQ & SSZ) should be first line." Please be sure to VOTE AGAIN on twitter (@ebrheum) after you have listened!
Version: 20230822